progression-free survival

You have access
Impact of Nab–Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer
NEELAKANTA DADI, MELISSA STANLEY, SAFI SHAHDA, BERT H. O'NEIL and AMIKAR SEHDEV

Anticancer Research October 2017, 37 (10) 5533-5539;
You have access
Correlation of Radiation Pneumonitis History Before Nivolumab with Onset of Interstitial Lung Disease and Progression-free Survival of Patients with Pre-treated Advanced Non-small Cell Lung Cancer
AKIHIRO TAMIYA, MOTOHIRO TAMIYA, KENJI NAKAHAMA, YOSHIHIKO TANIGUCHI, TAKAYUKI SHIROYAMA, SHUN-ICHI ISA, TAKAKO INOUE, KYOICHI OKISHIO, KAZUMI NISHINO, TORU KUMAGAI, HIDEKAZU SUZUKI, TOMONORI HIRASHIMA, FUMIO IMAMURA and SHINJI ATAGI

Anticancer Research September 2017, 37 (9) 5199-5205;
You have access
Efficacy of Nab-Paclitaxel as Second-line Chemotherapy for Unresectable or Recurrent Gastric Cancer
MINORU FUKUCHI, ERITO MOCHIKI, TORU ISHIGURO, TOSHIRO OGURA, JUN SOBAJIMA, YOUICHI KUMAGAI, KEIICHIRO ISHIBASHI and HIDEYUKI ISHIDA

Anticancer Research December 2016, 36 (12) 6699-6703;
You have access
Metastasectomy Improves Survival in Patients with Metastatic Urothelial Carcinoma
HIROAKI IWAMOTO, KOUJI IZUMI, YUSUKE SHIMURA, ARIUNBOLD NATSAGDORJ, AERKEN MAOLAKE, YUTA TAKEZAWA, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI

Anticancer Research October 2016, 36 (10) 5557-5561;
You have access
Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma
YUTA TAKEZAWA, KOUJI IZUMI, YUSUKE SHIMURA, MAOLAKE AERKEN, ARIUNBOLD NATSAGDORJI, MASASHI IIJIMA, KAZUYOSHI SHIGEHARA, TAKAHIRO NOHARA, KAZUTAKA NARIMOTO, YOSHIFUMI KADONO, YASUHIDE KITAGAWA, HIROYUKI KONAKA and ATSUSHI MIZOKAMI

Anticancer Research September 2016, 36 (9) 4961-4964;
You have access
Progression-free Survival as a Surrogate End-point in Advanced Colorectal Cancer Treated with Antiangiogenic Therapies
FRANCESCO MONTAGNANI, GRETA DI LEONARDO, MARIA SIMONA PINO, FRANCESCA MARTELLA, SIMONA PERBONI, ANGELA RIBECCO and LUISA FIORETTO

Anticancer Research August 2016, 36 (8) 4259-4265;
You have access
High Pre-treatment Plasma D-Dimer Level as a Potential Prognostic Biomarker for Cervical Carcinoma
KOHEI NAKAMURA, KENTARO NAKAYAMA, MASAKO ISHIKAWA, HIROSHI KATAGIRI, TOSHIKO MINAMOTO, TOMOKA ISHIBASHI, NORIYOSHI ISHIKAWA, EMI SATO, KAORI SANUKI, HITOMI YAMASHITA, TAKAYOSHI KOMATSU-FUJII and SATORU KYO

Anticancer Research June 2016, 36 (6) 2933-2938;
You have access
Efficacy and Safety Profile of Enzalutamide for Japanese Patients with Castration-resistant Prostate Cancer
MUTSUSHI YAMASAKI, TAKESHI YUASA, SHINYA YAMAMOTO, TATSURO HAYASHI, MASAHIRO OGAWA, MIZUAKI SAKURA, HITOSHI MASUDA, IWAO FUKUI and JUNJI YONESE

Anticancer Research January 2016, 36 (1) 361-365;
You have access
Platinum–Vinorelbine Induction Chemotherapy plus Bevacizumab With and Without Pemetrexed Switch Maintenance in Advanced NSCLC
LINDA MICHELSEN and JENS BENN SØRENSEN

Anticancer Research November 2015, 35 (11) 6255-6259;
You have access
No Significant Correlation of Clinical Outcomes Between First- and Second-line Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell Carcinoma
AKIRA MIYAZAKI, HIDEAKI MIYAKE, KEN-ICHI HARADA and MASATO FUJISAWA

Anticancer Research May 2015, 35 (5) 3067-3073;

Main menu

User menu

Search

progression-free survival

Pages